{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?page=49&status=ACTIVE_NOT_RECRUITING", "query": { "status": "ACTIVE_NOT_RECRUITING", "page": 49 }, "page_size": 10 }, "pagination": { "page": 49, "page_size": 10, "total_count": 10532, "total_pages": 1054, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=50&status=ACTIVE_NOT_RECRUITING&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=48&status=ACTIVE_NOT_RECRUITING&page_size=10" }, "source": "local", "last_synced_at": "2026-11-11T12:47:07.259Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07546812", "title": "Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Esophageal Adenocarcinoma", "Gastric Adenocarcinoma", "Gastroesophageal Junction", "HER2-negative" ], "interventions": [ { "name": "Denikitug", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Ramucirumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2026-08-07", "completion_date": "2030-01", "has_results": false, "last_update_posted_date": "2026-11-10", "last_synced_at": "2026-11-10T14:55:45.168Z", "location_count": 4, "location_summary": "Boston, Massachusetts • Albany, New York • New York, New York", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Albany", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07546812" }, { "nct_id": "NCT07534592", "title": "A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Elecoglipron", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 48, "start_date": "2026-04-16", "completion_date": "2027-01-25", "has_results": false, "last_update_posted_date": "2026-11-10", "last_synced_at": "2026-11-11T01:37:46.906Z", "location_count": 2, "location_summary": "Glendale, California • Brooklyn, Maryland", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Brooklyn", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07534592" }, { "nct_id": "NCT07425769", "title": "Adapting RDAD for DS", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer's Disease (AD)", "Down Syndrome (DS)" ], "interventions": [ { "name": "Caregiver Education Sessions", "type": "BEHAVIORAL" }, { "name": "Remote Exercise Sessions", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 40, "start_date": "2026-03-31", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-11-10", "last_synced_at": "2026-11-11T12:47:07.259Z", "location_count": 1, "location_summary": "Kansas City, Kansas", "locations": [ { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07425769" }, { "nct_id": "NCT07400107", "title": "AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2", "Obesity", "Overweight" ], "interventions": [ { "name": "NNC0487-0111", "type": "DRUG" }, { "name": "Placebo (matched to NNC0487-0111)", "type": "DRUG" }, { "name": "Placebo (matched to semaglutide)", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 985, "start_date": "2026-05-20", "completion_date": "2028-12-19", "has_results": false, "last_update_posted_date": "2026-11-10", "last_synced_at": "2026-11-10T14:01:46.443Z", "location_count": 10, "location_summary": "Hollywood, Florida • Orange City, Florida • Weston, Florida + 7 more", "locations": [ { "city": "Hollywood", "state": "Florida" }, { "city": "Orange City", "state": "Florida" }, { "city": "Weston", "state": "Florida" }, { "city": "Roswell", "state": "Georgia" }, { "city": "Blackfoot", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT07400107" }, { "nct_id": "NCT07340320", "title": "A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type II Diabetes Mellitus" ], "interventions": [ { "name": "CX11", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Corxel Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 251, "start_date": "2026-02-06", "completion_date": "2027-04-15", "has_results": false, "last_update_posted_date": "2026-11-10", "last_synced_at": "2026-11-10T14:08:30.919Z", "location_count": 30, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Cerritos, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Cerritos", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07340320" }, { "nct_id": "NCT07265479", "title": "A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Tapinarof cream, 1%", "type": "DRUG" }, { "name": "Vehicle Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Organon and Co", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "23 Months", "sex": "ALL", "summary": "3 Months to 23 Months" }, "enrollment_count": 187, "start_date": "2025-12-29", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-11-10", "last_synced_at": "2026-11-10T14:02:24.701Z", "location_count": 36, "location_summary": "Birmingham, Alabama • Bryant, Arkansas • Los Angeles, California + 32 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Bryant", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07265479" }, { "nct_id": "NCT07232719", "title": "A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obesity", "Overweight" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Retatrutide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2025-11-17", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-11-10", "last_synced_at": "2026-11-10T18:35:12.882Z", "location_count": 19, "location_summary": "Riverside, California • Atlantis, Florida • Orlando, Florida + 16 more", "locations": [ { "city": "Riverside", "state": "California" }, { "city": "Atlantis", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tamarac", "state": "Florida" }, { "city": "Arlington Heights", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07232719" }, { "nct_id": "NCT07228390", "title": "A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hidradenitis Suppurativa" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Ritlecitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 128, "start_date": "2025-11-13", "completion_date": "2027-01-05", "has_results": false, "last_update_posted_date": "2026-11-10", "last_synced_at": "2026-11-10T22:53:21.399Z", "location_count": 30, "location_summary": "Hot Springs, Arkansas • Fountain Valley, California • Northridge, California + 22 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07228390" }, { "nct_id": "NCT07223736", "title": "Postpartum Education Via Artificial Intelligence for Recovery and Loneliness: A Randomized Controlled Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Artificial Intelligence (AI)", "Chatbot", "Depression", "Loneliness", "Mental Health", "Pelvic Floor Disorder", "Peritraumatic Distress", "Postpartum", "Women" ], "interventions": [ { "name": "Generative artificial intelligence (genAI) postpartum chatbot", "type": "OTHER" }, { "name": "Standard of Care (SOC)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 130, "start_date": "2026-01-08", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-11-10", "last_synced_at": "2026-11-10T14:38:42.837Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07223736" }, { "nct_id": "NCT07215624", "title": "Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Malignant Digestive System Neoplasm", "Malignant Female Reproductive System Neoplasm", "Malignant Genitourinary System Neoplasm" ], "interventions": [ { "name": "Non-Interventional Study", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2026-01-15", "completion_date": "2027-06-01", "has_results": false, "last_update_posted_date": "2026-11-10", "last_synced_at": "2026-11-10T15:16:08.972Z", "location_count": 103, "location_summary": "Kingman, Arizona • Fort Smith, Arkansas • Oakland, California + 81 more", "locations": [ { "city": "Kingman", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Oakland", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Clara", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07215624" } ] }